DelveInsight has launched a new report on “Gastroparesis Market Insights, Epidemiology, and Market Forecast-2032”.
DelveInsight’s “Gastroparesis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of Gastroparesis, historical and forecasted epidemiology as well as the Gastroparesis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Gastroparesis Market Report:
- The market size of Gastroparesis was estimated to be USD 3,219 Million in the year 2021
- In the year 2021, the total prevalence of Gastroparesis in the 7MM was 34,243,222 cases
- Among the 7MM countries the highest prevalence of Gastroparesis was observed in the United States with around 13, 569,432 in the year 2021
- The Gender-based study of Gastroparesis shows that a higher prevalence of Gastroparesis is observed in females than in males
- It was observed that among the total gastroparesis cases in the United States, 4,790,204 had idiopathic gastroparesis. In contrast, only 3,871,746 patients had diabetic gastroparesis, followed by post-surgical gastroparesis.
Request a sample for the Report:
Key benefits of the report:
- Gastroparesis market report covers a descriptive overview and comprehensive insight of the Gastroparesis Epidemiology and Gastroparesis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Gastroparesis market report provides insights on the current and emerging therapies.
- Gastroparesis market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Gastroparesis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Gastroparesis market.
Got queries? Click here to know more about the Gastroparesis Market Landscape
Gastroparesis, which is a translated meaning of “stomach paralysis”, is a digestive disorder characterized by delayed gastric emptying of solid food in the absence of mechanical obstruction of the stomach, resulting in the cardinal symptoms of early satiety, postprandial fullness, nausea, vomiting, belching, and bloating.
Several factors may contribute to or cause gastroparesis, which is mostly unknown, and is, therefore, termed “idiopathic.” Based on the causes, gastroparesis is divided into three type namely idiopathic, diabetic, and post-surgical gastroparesis.
The symptoms of Gastroparesis include –
- Vomiting and Nausea
- Pain in the abdominal area
- Abdominal bloating
- A feeling of fullness after eating a few bites
- Acid reflux
- Changes in blood sugar levels
The dynamics of the Gastroparesis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as PCS12852, Relamorelin, and others during the forecasted period 2019-2032.
Learn more by requesting for sample @Gastroparesis Market Landscape
- Theravance Biopharma
- Eli Lilly and Company
- Processa Pharmaceuticals
- PTC Therapeutics
Table of Contents
- Gastroparesis Market Report Introduction
- Executive Summary
- SWOT analysis
- Gastroparesis Patient Share (%) Overview at a Glance
- Gastroparesis Market Overview at a Glance
- Gastroparesis Disease Background and Overview
- Gastroparesis Epidemiology and Patient Population
- Country-Specific Patient Population of Gastroparesis
- Gastroparesis Current Treatment and Medical Practices
- Gastroparesis Unmet Needs
- Gastroparesis Emerging Therapies
- Gastroparesis Market Outlook
- Country-Wise Gastroparesis Market Analysis (2018–2030)
- Market Access and Reimbursement of Therapies
- Market drivers
- Market barriers
- Gastroparesis Report Methodology
- DelveInsight Capabilities
- About DelveInsight
Click here to read more about Gastroparesis Market Outlook 2032
“Gastroparesis Pipeline Insight, 2022″ report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Gastroparesis market. A detailed picture of the Gastroparesis pipeline landscape is provided, which includes the disease overview and Gastroparesis treatment guidelines.
DelveInsight’s ‘Gastroparesis Epidemiology Forecast to 2032′ report delivers an in-depth understanding of the disease, historical and forecasted Gastroparesis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Diagnostic Imaging Equipment Market
Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases.
Invasive Candidiasis Market
“DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW.
DelveInsight’s “Sialidosis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Filgrastim Biosimilar Insight
DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Pain Management Devices Market
Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027
Latest Reports by DelveInsight
Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis Market | Lupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market
To know more about our Competitive Services, Click here: Pharma Competitive Intelligence
Also, take a glance at the Blogs by DelveInsight:
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: [email protected]
State: New York
Country: United States